Hudson Bay Capital Management Portfolio holdings
AUM
$15.2B
1-Year Return
11.47%
This Quarter Return
+2.77%
1 Year Return
+11.47%
3 Year Return
+62.45%
5 Year Return
+105.91%
10 Year Return
+214.7%
AUM
$16.6B
AUM Growth
+$2.06B
(+14%)
Cap. Flow
-$860M
Cap. Flow
% of AUM
-5.19%
Top 10 Holdings %
Top 10 Hldgs %
30.4%
Holding
951
New
253
Increased
184
Reduced
160
Closed
190
Top Buys
| 1 |
Tesla
TSLA
|
$224M |
| 2 |
UnitedHealth
UNH
|
$223M |
| 3 |
Strategy Inc Common Stock Class A
MSTR
|
$156M |
| 4 |
Arm
ARM
|
$148M |
| 5 |
Eli Lilly
LLY
|
$145M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$608M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$297M |
| 3 |
NVIDIA
NVDA
|
$285M |
| 4 |
Broadcom
AVGO
|
$275M |
| 5 |
Invesco QQQ Trust
QQQ
|
$211M |
Sector Composition
| 1 | Technology | 27.98% |
| 2 | Consumer Discretionary | 11.16% |
| 3 | Financials | 10.96% |
| 4 | Healthcare | 7.38% |
| 5 | Real Estate | 4.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VCIC
351
Vine Hill Capital Investment Corp. Class A Ordinary Shares
VCIC
| $4.52M | 0.02% |
+450,000
| New | +$4.52M |
|
352
Masco
MAS
$15.9B
| $4.48M | 0.02% |
61,799
-52,201
| -46% | -$3.79M |
|
353
Kiniksa Pharmaceuticals
KNSA
$2.65B
| $4.45M | 0.02% |
225,000
+135,000
| +150% | +$2.67M |
|
|
354
Alphabet (Google) Class C
GOOG
$2.84T
| $4.44M | 0.02% |
23,331
-1,558,759
| -99% | -$297M |
|
355
Syndax Pharmaceuticals
SNDX
$1.47B
| $4.44M | 0.02% |
336,000
-89,000
| -21% | -$1.18M |
|
|
RC
356
Ready Capital
RC
$705M
| $4.39M | 0.02% |
+644,139
| New | +$4.39M |
|
357
VICI Properties
VICI
$35.8B
| $4.33M | 0.02% |
148,254
+61
| +0% | +$1.78K |
|
|
CHEB
358
DELISTED
Chenghe Acquisition II Co.
CHEB
| $4.28M | 0.02% |
423,404
+248,404
| +142% | +$2.51M |
|
359
iShares US Home Construction ETF
ITB
$3.35B
| $4.28M | 0.02% |
41,400
| – | – |
|
360
Quetta Acquisition Corp
QETA
| $4.27M | 0.02% |
404,900
| – | – |
|
361
Wabtec
WAB
$33B
| $4.17M | 0.01% |
+22,010
| New | +$4.17M |
|
362
Exelixis
EXEL
$10.2B
| $4.16M | 0.01% |
+125,000
| New | +$4.16M |
|
363
Celestica
CLS
$27.9B
| $4.15M | 0.01% |
45,000
+27,000
| +150% | +$2.49M |
|
364
Neurocrine Biosciences
NBIX
$14.3B
| $4.14M | 0.01% |
30,342
-9,658
| -24% | -$1.32M |
|
365
Mondelez International
MDLZ
$79.9B
| $4.08M | 0.01% |
68,337
-30,981
| -31% | -$1.85M |
|
366
Modine Manufacturing
MOD
$7.1B
| $4.06M | 0.01% |
+35,000
| New | +$4.06M |
|
367
Vertex Pharmaceuticals
VRTX
$102B
| $4.03M | 0.01% |
10,015
-19,985
| -67% | -$8.05M |
|
|
HSPTU
368
Horizon Space Acquisition II Corp. Units
HSPTU
| $4.02M | 0.01% |
+400,000
| New | +$4.02M |
|
|
CLBR
369
DELISTED
Colombier Acquisition Corp II
CLBR
| $4M | 0.01% |
340,848
-439,173
| -56% | -$5.16M |
|
370
Mastercard
MA
$528B
| $3.99M | 0.01% |
+7,582
| New | +$3.99M |
|
371
Incyte
INCY
$16.9B
| $3.97M | 0.01% |
57,509
-164,065
| -74% | -$11.3M |
|
|
ETHMU
372
Dynamix Corporation Unit
ETHMU
$170M
| $3.97M | 0.01% |
+400,000
| New | +$3.97M |
|
373
Samsara
IOT
$24B
| $3.96M | 0.01% |
+90,744
| New | +$3.96M |
|
374
Baxter International
BAX
$12.5B
| $3.94M | 0.01% |
135,029
+50,029
| +59% | +$1.46M |
|
375
GXO Logistics
GXO
$6.02B
| $3.92M | 0.01% |
90,000
+85,000
| +1,700% | +$3.7M |
|